TIMP1 and pancreatic ductal adenocarcinoma: A similar observation has also been reported for pancreatic ductal adenocarcinoma, where exogenous addition of human recombinant TIMP‐1 significantly increased proliferation of pancreatic ductal cells, but only in KRAS‐transformed cells (Botta et al., 2013).